Our team will work closely with you to monitor your progress, adjust your treatment plan as needed, and address any side effects or concerns
G protein-coupled receptors targeting insulin resistance, obesity, and type 2 diabetes mellitus
*Correspondence: Carla Pelusi, [email protected] This article was submitted to Clinical Diabetes, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
A research study by the National Center for Biotechnology Information (NCBI) mentions the production of GLP-1s using rDNA technology
"Americans keep continuing to gain weight." The desire to lose weight may not just be about health
You message your care team about side effects, request dose adjustments, log your progress